undefined undefined
NaN.000
NaN.00%
Immunocore Hldgs(IMCR.US):2024年Q1财报实现营收7050.2万美元,前值为5509.3万美元,预期值为7115万美元;每股收益为...
05-08 21:41
In a report released on May 2, Naureen Quibria from Capital One Financial reite...
05-06 14:25
10 analysts have shared their evaluations of Immunocore Hldgs (NASDAQ:IMCR) dur...
04-29 23:01
Shares of Exelixis (NASDAQ:EXEL) traded lower on Thursday after Barclays downgraded the cancer drugmaker, citing an insufficient catalyst path in the near-to-medium term, while its lead asset, cabozan...
04-11 22:10
Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。
04-11 18:40
Immunocore Holdings (NASDAQ:IMCR) disclosed in an SEC filing on Wednesday after the bell a prospectus to offer and sell ordinary shares, American Depositary Shares representing ordinary shares, debt s...
03-21 22:56
Immunocore Filed For Mixed Shelf Up To $250M Of ADSs
03-21 18:08
Key Insights Using the 2 Stage Free Cash Flow to Equity, Immunocore Holdings ...
03-06 06:42
Immunocore Hldgs (NASDAQ:IMCR) has been analyzed by 4 analysts in the last thre...
03-01 00:00